newsfilter
← Latest News
GlobeNewswire·

Idera Pharmaceuticals Announces Corporate Updates

EXTON, Pa., May 18, 2021 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. ("Idera" or the "Company") (NASDAQ:IDRA) today announced that it will not continue ILLUMINATE-301, the Company's trial of tilsotolimod in combination with ipilimumab versus ipilim